59. J Immunol Res. 2018 Feb 5;2018:2584243. doi: 10.1155/2018/2584243. eCollection2018.Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in BreastCancer.Aponte-López A(1)(2), Fuentes-Pananá EM(1), Cortes-Muñoz D(3), Muñoz-Cruz S(4).Author information: (1)Unidad de Investigación en Virología y Cáncer, Hospital Infantil de MéxicoFederico Gómez, Dr. Márquez 162, Doctores, Cuauhtémoc, 06720 Ciudad de Mexico,Mexico.(2)Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma deMéxico (UNAM), Ciudad de México, Mexico.(3)Programa de Servicio Social en Investigación en Salud, Departamento deInmunología y Reumatología, Instituto Nacional de Ciencias Médicas y NutriciónSalvador Zubirán, Vasco de Quiroga 15, Tlalpan, 14080 Ciudad de Mexico, Mexico.(4)Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias,Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, AvenidaCuauhtémoc 330, Doctores, Cuauhtémoc, 06720 Ciudad de Mexico, Mexico.Mast cells are unique tissue-resident immune cells that secrete a diverse arrayof biologically active compounds that can stimulate, modulate, or suppress theimmune response. Although mounting evidence supports that mast cells areconsistently infiltrating tumors, their role as either a driving or an oppositeforce for cancer progression is still controversial. Particularly, in breastcancer, their function is still under discussion. While some studies have shown aprotective role, recent evidence indicates that mast cells enhance blood andlymphatic vessel formation. Interestingly, one of the most important componentsof the mast cell cargo, the serine protease tryptase, is a potent angiogenicfactor, and elevated serum tryptase levels correlate with bad prognosis in breastcancer patients. Likewise, histamine is known to induce tumor cell proliferation and tumor growth. In agreement, mast cell depletion reduces the size of mammarytumors and metastasis in murine models that spontaneously develop breast cancer. In this review, we will discuss the evidence supporting protumoral andantitumoral roles of mast cells, emphasizing recent findings placing mast cellsas important drivers of tumor progression, as well as the potential use of these cells or their mediators as therapeutic targets.DOI: 10.1155/2018/2584243 PMCID: PMC5832101PMID: 29651440 